ijms-logo

Journal Browser

Journal Browser

New Advances in Neural Therapeutic Application of Mesenchymal Stem Cells

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 840

Special Issue Editors


E-Mail Website
Guest Editor
Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, Università degli Studi di Messina, Viale Ferdinando Stagno d’Alcontres 31, 98166 Messina, Italy
Interests: adipose-derived stem cells; neural differentiation; conditioned media; Schwann cells; olfactory ensheathing cells
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Biomedical and Biotechnological Sciences, Section of Physiology, University of Catania, Via S. Sofia 97, 95123 Catania, Italy
Interests: mesenchymal stem cells; cell differentiation; intercellular communication
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Mesenchymal stem cells (MSCs) can differentiate into endodermal and ectodermal cells, including neurons and glial cells. For this reason, MSCs can be suitable for cell-based therapeutic strategies, especially in pathologies where pharmacological treatments give poor results. MSCs may be useful in the case of central nervous system injury (e.g., stroke, spinal cord injury) and irreversible neurological disorders (e.g., Parkinson’s disease, Alzheimer’s disease) characterized by progressive neuronal death, in which behavioral and cognitive functions of patients inexorably decline as the disease progresses.

This Special Issue entitled “New Advances in Neural Therapeutic Application of Mesenchymal Stem Cells” focuses on the possible roles of MSCs for the treatment of disabling neurodegenerative disorders or central nervous system injury.

Mechanisms of MSC-induced beneficial effects include neurogenesis and angiogenesis stimulation and immunomodulatory, anti-inflammatory, and antiapoptotic actions. Moreover, the paracrine release of neurotrophic factors and cytokines, mainly delivered at damaged regions, may help to restore tissue homeostasis.

This Special Issue welcomes bioinformatic analyses, review articles, and original data focusing on the use of MSCs in cell-replacement therapies aimed at restoring disease-disrupted brain circuitry.

Dr. Giuliana Mannino
Dr. Debora Lo Furno
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

 

Keywords

  • mesenchymal stem cells
  • neural differentiation
  • nervous system injury
  • neurological diseases
  • regenerative medicine

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

20 pages, 48075 KiB  
Article
Melatonin Enhances Neural Differentiation of Adipose-Derived Mesenchymal Stem Cells
by Ivana Roberta Romano, Floriana D’Angeli, Elisa Gili, Mary Fruciano, Giuseppe Angelo Giovanni Lombardo, Giuliana Mannino, Nunzio Vicario, Cristina Russo, Rosalba Parenti, Carlo Vancheri, Rosario Giuffrida, Rosalia Pellitteri and Debora Lo Furno
Int. J. Mol. Sci. 2024, 25(9), 4891; https://doi.org/10.3390/ijms25094891 - 30 Apr 2024
Viewed by 491
Abstract
Adipose-derived mesenchymal stem cells (ASCs) are adult multipotent stem cells, able to differentiate toward neural elements other than cells of mesodermal lineage. The aim of this research was to test ASC neural differentiation using melatonin combined with conditioned media (CM) from glial cells. [...] Read more.
Adipose-derived mesenchymal stem cells (ASCs) are adult multipotent stem cells, able to differentiate toward neural elements other than cells of mesodermal lineage. The aim of this research was to test ASC neural differentiation using melatonin combined with conditioned media (CM) from glial cells. Isolated from the lipoaspirate of healthy donors, ASCs were expanded in a basal growth medium before undergoing neural differentiation procedures. For this purpose, CM obtained from olfactory ensheathing cells and from Schwann cells were used. In some samples, 1 µM of melatonin was added. After 1 and 7 days of culture, cells were studied using immunocytochemistry and flow cytometry to evaluate neural marker expression (Nestin, MAP2, Synapsin I, GFAP) under different conditions. The results confirmed that a successful neural differentiation was achieved by glial CM, whereas the addition of melatonin alone did not induce appreciable changes. When melatonin was combined with CM, ASC neural differentiation was enhanced, as demonstrated by a further improvement of neuronal marker expression, whereas glial differentiation was attenuated. A dynamic modulation was also observed, testing the expression of melatonin receptors. In conclusion, our data suggest that melatonin’s neurogenic differentiation ability can be usefully exploited to obtain neuronal-like differentiated ASCs for potential therapeutic strategies. Full article
Show Figures

Figure 1

Back to TopTop